NCT02238860View on ClinicalTrials.gov

A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis

PHASE4UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Cirrhosis Due to Hepatitis B
Interventions
DRUG

Entacavir

Entacavir-0.5 mg ,OD,for

DRUG

Tenofovir

Tenofovir ,300 mg,OD,for 48 weeks

Trial Locations (1)

71800

RECRUITING

Asian Institute of medical Sciences, Hyderābād

Sponsors
All Listed Sponsors
lead

Asian Institute Of Medical Sciences

OTHER